Open AccessEmpagliflozin in heart failure patients with preserved ejection fraction and diabetes mellitus type 2. (Results of a pilot prospective randomized trial)
Author(s) -
А Г Овчинников,
А. А. Борисов,
K.Yu. Zherebchikova,
O Yu Ryabtseva,
Anna Gvozdeva,
В П Масенко,
Ф Т Агеев
Publication year - 2021
Publication title -
kardiologičeskij vestnik
Language(s) - English
Resource type - Journals
eISSN - 2712-889X
pISSN - 2077-6764
DOI - 10.17116/cardiobulletin20211603160
Subject(s) - empagliflozin , ejection fraction , medicine , heart failure , randomized controlled trial , cardiology , type 2 diabetes mellitus , diabetes mellitus , type 2 diabetes , prospective cohort study , endocrinology